Blackhill Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57.2M | Buy |
263,110
+16,000
| +6% | +$3.55M | 2.95% | 4 |
|
|
2025
Q4 | $56.5M | Buy |
247,110
+300
| +0.1% | +$68.3K | 2.91% | 4 |
|
|
2025
Q3 | $57.1M | Sell |
246,810
-6,000
| -2% | -$1.22M | 2.83% | 4 |
|
|
2025
Q2 | $46.9M | Sell |
252,810
-6,000
| -2% | -$1.12M | 2.71% | 4 |
|
|
2025
Q1 | $54.2M | Hold |
258,810
| – | – | 3.15% | 4 |
|
|
2024
Q4 | $46M | Hold |
258,810
| – | – | 2.38% | 4 |
|
|
2024
Q3 | $51.1M | Sell |
258,810
-10,000
| -4% | -$1.87M | 2.94% | 4 |
|
|
2024
Q2 | $46.1M | Buy |
268,810
+18,400
| +7% | +$3.05M | 2.86% | 4 |
|
|
2024
Q1 | $45.6M | Sell |
250,410
-250
| -0.1% | -$43.1K | 2.62% | 3 |
|
|
2023
Q4 | $38.8M | Hold |
250,660
| – | – | 3.11% | 4 |
|
|
2023
Q3 | $37.4M | Sell |
250,660
-10,200
| -4% | -$1.5M | 3.6% | 4 |
|
|
2023
Q2 | $35.1M | Sell |
260,860
-2,400
| -0.9% | -$352K | 3.77% | 4 |
|
|
2023
Q1 | $42M | Buy |
263,260
+3,700
| +1% | +$566K | 4.68% | 4 |
|
|
2022
Q4 | $41.9M | Hold |
259,560
| – | – | 4.86% | 3 |
|
|
2022
Q3 | $34.8M | Buy |
259,560
+3,400
| +1% | +$488K | 4.14% | 4 |
|
|
2022
Q2 | $39.2M | Sell |
256,160
-1,600
| -0.6% | -$244K | 4.55% | 3 |
|
|
2022
Q1 | $41.8M | Buy |
257,760
+6,000
| +2% | +$872K | 3.97% | 4 |
|
|
2021
Q4 | $34.1M | Hold |
251,760
| – | – | 2.91% | 6 |
|
|
2021
Q3 | $27.2M | Hold |
251,760
| – | – | 2.35% | 8 |
|
|
2021
Q2 | $28.4M | Buy |
251,760
+4,200
| +2% | +$473K | 2.58% | 8 |
|
|
2021
Q1 | $26.8M | Buy |
247,560
+300
| +0.1% | +$32.1K | 2.34% | 8 |
|
|
2020
Q4 | $26.5M | Hold |
247,260
| – | – | 3.2% | 7 |
|
|
2020
Q3 | $21.7M | Sell |
247,260
-2,000
| -0.8% | -$188K | 2.93% | 9 |
|
|
2020
Q2 | $24.5M | Buy |
249,260
+55,290
| +29% | +$4.87M | 3.6% | 7 |
|
|
2020
Q1 | $14.8M | Buy |
193,970
+400
| +0.2% | +$34.1K | 3.08% | 10 |
|
|
2019
Q4 | $17.1M | Buy |
193,570
+10,400
| +6% | +$863K | 2.5% | 10 |
|
|
2019
Q3 | $13.9M | Sell |
183,170
-3,600
| -2% | -$247K | 2.19% | 12 |
|
|
2019
Q2 | $13.6M | Hold |
186,770
| – | – | 2.19% | 11 |
|
|
2019
Q1 | $15.1M | Buy |
186,770
+9,600
| +5% | +$785K | 2.58% | 10 |
|
|
2018
Q4 | $16.3M | Sell |
177,170
-3,390
| -2% | -$298K | 3.13% | 10 |
|
|
2018
Q3 | $17.1M | Sell |
180,560
-200
| -0.1% | -$19K | 2.76% | 10 |
|
|
2018
Q2 | $16.7M | Sell |
180,760
-11,900
| -6% | -$1.16M | 2.98% | 7 |
|
|
2018
Q1 | $18.2M | Sell |
192,660
-3,000
| -2% | -$330K | 3.4% | 7 |
|
|
2017
Q4 | $18.9M | Sell |
195,660
-8,000
| -4% | -$754K | 3.41% | 7 |
|
|
2017
Q3 | $18.1M | Hold |
203,660
| – | – | 3.4% | 8 |
|
|
2017
Q2 | $14.8M | Hold |
203,660
| – | – | 2.83% | 8 |
|
|
2017
Q1 | $13.3M | Sell |
203,660
-3,500
| -2% | -$220K | 2.45% | 10 |
|
|
2016
Q4 | $13M | Sell |
207,160
-10,000
| -5% | -$610K | 2.46% | 8 |
|
|
2016
Q3 | $13.7M | Sell |
217,160
-8,000
| -4% | -$518K | 2.28% | 9 |
|
|
2016
Q2 | $13.9M | Hold |
225,160
| – | – | 2.26% | 10 |
|
|
2016
Q1 | $12.9M | Sell |
225,160
-30,000
| -12% | -$1.67M | 2.11% | 10 |
|
|
2015
Q4 | $15.1M | Hold |
255,160
| – | – | 2.35% | 9 |
|
|
2015
Q3 | $13.9M | Sell |
255,160
-400
| -0.2% | -$26K | 1.87% | 10 |
|
|
2015
Q2 | $17.2M | Hold |
255,560
| – | – | 2.07% | 8 |
|
|
2015
Q1 | $15M | Sell |
255,560
-1,400
| -0.5% | -$84.6K | 1.82% | 11 |
|
|
2014
Q4 | $16.8M | Hold |
256,960
| – | – | 2.1% | 9 |
|
|
2014
Q3 | $14.8M | Hold |
256,960
| – | – | 2.02% | 10 |
|
|
2014
Q2 | $14.5M | Sell |
256,960
-3,800
| -1% | -$199K | 1.97% | 8 |
|
|
2014
Q1 | $13.4M | Sell |
260,760
-6,000
| -2% | -$303K | 1.93% | 9 |
|
|
2013
Q4 | $14.1M | Sell |
266,760
-1,900
| -0.7% | -$93.4K | 2.14% | 9 |
|
|
2013
Q3 | $12M | Hold |
268,660
| – | – | 1.93% | 9 |
|
|
2013
Q2 | $11.1M | Buy |
+268,660
| New | +$11.7M | 1.8% | 10 |
|
Other funds holding ABBV
VCM
VPM
Blackhill Capital's ABBV Position: Q1 2026 in Review
Blackhill Capital increased its AbbVie (ABBV) stake by 6.5% in Q1 2026, buying an estimated $3.55M and bringing the position to 263,110 shares worth $57.2M. The position accounts for 2.95% of the portfolio, ranked #4.
Blackhill Capital first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Blackhill Capital held 263,110 shares of AbbVie worth $57.2M as of Q1 2026.
- Blackhill Capital bought 16,000 AbbVie shares in Q1 2026, an estimated $3.55M.
- AbbVie made up 2.95% of Blackhill Capital's portfolio in Q1 2026, its #4 holding.
- Blackhill Capital first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Blackhill Capital's 13F filing for Q1 2026, filed 14 May 2026.